ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, today announced the second close of its Series D financing round, adding $13 million and increasing ...

Investors poured a further $13 million into Vicentra BV for Kaleido, its insulin patch pump system, taking the total raised in the company’s series D financing round to $98 million. The funds come ...

Bringing its total Series D funds to $98m, ViCentra plans to boost manufacturing capabilities for its Kaleido insulin pump ...

ViCentra is expanding production and international operations while advancing its Kaleido insulin patch pump to support ...

Diabetics typically have to receive insulin via daily injections, or sometimes even from implanted pumps. According to a new study, however, a simple inner-cheek patch could one day provide a far less ...

Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support "Our goal is to simplify diabetes management and ...

Managing blood sugar levels requires round-the-clock attention for people diagnosed with diabetes. A more healthful diet and increased physical activity can help, but many with the condition also need ...

DUBLIN--(BUSINESS WIRE)--The "Insulin Patch Pumps Market Size, Share & Trends Analysis Report by Delivery Mode (Basal, Bolus, Basal & Bolus), by Product Type (Disposable, Reusable), by Distribution ...

Please provide your email address to receive an email when new articles are posted on . Next year will mark the centennial of the discovery of insulin by the Canadian surgeon Frederick Banting and ...